DALLAS / Aug 10, 2023 / Business Wire / Tenet Healthcare Corporation (NYSE: THC) today announced that its Board of Directors has elected Chief Executive Officer, Saum Sutaria, M.D., to assume the additional position of Chairman, effective immediately. Sutaria succeeds Senator J. Robert Kerrey, who will transition to Lead Director of the Board, a role he previously held from 2017- 2022.
Sutaria has served as Tenet Healthcare’s CEO since September 2021 and a member of the Board of Directors since 2020. Previously, he served as the Company’s Chief Operating Officer.
“The appointment of Saum to Chairman is a testament to his steadfast leadership and commitment to Tenet Healthcare,” said Senator J. Robert Kerrey, Lead Director. “The Board looks forward to working closely with him in this new capacity to continue to create value for all our stakeholders.”
About Tenet Healthcare
Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates or has ownership interests in more than 475 ambulatory surgery centers and surgical hospitals. We also operate 61 acute care and specialty hospitals, approximately 110 other outpatient facilities, a network of leading employed physicians and a global business center in Manila, Philippines. Our Conifer Health Solutions subsidiary provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers, and other clients. Across the Tenet enterprise, we are united by our mission to deliver quality, compassionate care in the communities we serve. For more information, please visit www.tenethealth.com.
Last Trade: | US$202.00 |
Daily Change: | 5.28 2.68 |
Daily Volume: | 970,022 |
Market Cap: | US$17.850B |
July 22, 2025 April 29, 2025 February 12, 2025 October 29, 2024 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load